About Pkd Foundation
A defining feature of PKD Foundation grantmaking is its repeated support for the same research centers across multiple years, including University of Kansas Medical Center Research Institute, Mayo Clinic, and Yale University. That pattern fits a funder centered on polycystic kidney disease research and care, with grants that reach investigators, fellows, clinical centers, and patient-facing programs tied to ADPKD and ARPKD.
The foundation’s recent awards show a strong research orientation. University of Kansas Medical Center Research Institute received $380,000 in 2025 and $220,000 in 2024, while University of Colorado received $287,000 in 2025 and $190,000 in 2023. Mayo Clinic appears as another recurring recipient, with $260,000 in 2025, $120,000 in 2024, and $100,000 in 2023. Yale University also appears more than once, including $200,000 in 2024 and $140,000 in 2023. These grants indicate support for research, investigator development, and clinical care infrastructure around PKD rather than isolated one-time awards.
The foundation’s program mix includes research grants, fellowships, a patient registry resource, and Centers of Excellence support, all aligned with PKD science and care. Its funding reaches major academic medical centers and also supports early-career researchers through fellowship-related awards.
What Pkd Foundation Funds
PKD Foundation supports a wide set of PKD research and care activities, but the recurring themes are translational research, investigator development, and clinical infrastructure.
In translational work, Yale University received $200,000 in 2024 for an investigator grant, drug repurposing, care center grant, and fellowship support, showing interest in therapeutic development as well as center-level care. In early-career development, Mayo Clinic received $120,000 in 2024 for a young investigator grant and core grant, and $100,000 in 2023 for a fellowship grant and center of excellence support.
The foundation also funds research tied to core scientific and clinical capacity. University of Alabama at Birmingham received $160,000 in 2025 for a research grant, while Johns Hopkins University received $80,000 in 2025 for a research grant. Across these awards, the grant purposes point to PKD research, clinical study support, and research infrastructure rather than only one clinical niche.